The 2010 winter saw an excess of serious adverse events linked to the CSL influenza vaccine. With another influenza season over, the MJA investigates what progress has been made to ensure it does not happen again.
Eighteen months ago, Dr Darryl Maher received news that changed his working life. He learnt that the seasonal influenza vaccine made by CSL Biotherapies had been linked to serious adverse reactions in children, such as high fevers and febrile seizures.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.